CN106728650A - 一种治疗高脂血症的胶囊剂药物及其制备方法 - Google Patents
一种治疗高脂血症的胶囊剂药物及其制备方法 Download PDFInfo
- Publication number
- CN106728650A CN106728650A CN201710090841.XA CN201710090841A CN106728650A CN 106728650 A CN106728650 A CN 106728650A CN 201710090841 A CN201710090841 A CN 201710090841A CN 106728650 A CN106728650 A CN 106728650A
- Authority
- CN
- China
- Prior art keywords
- medicine
- hyperlipidemia
- desmodium
- feverfew
- mass parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药制剂领域,目的是根据中医对高脂血症的认识机理而提供的一种治疗高脂血症的胶囊剂药物,所述药物的各个组分及其质量份比如下:白菊花500~960g、荷叶50~160g、泽泻100~220g、桑白皮90~160g、枳壳30~100g、山楂100~220g、香附80~160g、金钱草150~650g、决明子80~180g、茵陈60~160g、莱菔子50~120g;本发明提供的药物是一个标本兼治的中药组方。
Description
技术领域
本发明属于中药制剂领域,具体涉及一种治疗高脂血症的胶囊剂药物,特别是供高脂血症患者使用的胶囊剂药物及其制备方法的领域。
背景技术
祖国医学认为:高脂血症是指血脂水平过高,可直接引起一些严重危害人体健康的疾病,如动脉粥样硬化、冠心病、胰腺炎等。
随着人们生活水平的不断提高和饮食结构的不断改善,人们生活方式的变化及遗传基因等因素,高脂血症的发病率呈明显上升趋势。高脂血症是目前中老年人的常见病、多发病,由高脂血症所致的心脑血管疾病是世界上死亡率最高的病种之一,且发病率呈逐年上升的趋势,对人类健康的危害越来越大,已成为心脑血管疾病发生的重要因素之一。
那么,就如何找到一种可有效治疗上述高脂血症的药物,是本领域技术人员亟待要解决的课题。
发明内容
随着我国中医中药学的不断发展,在治疗高脂血症上,人们逐渐意识到了中医治疗高脂血症的优点,且在治疗过程中疗效好、见效快、毒副作用小等优势,针对现有西医治疗高脂血症的现状,本发明的目的是在于提供一种治疗高脂血症的胶囊剂药物,以解决高脂血症患者早日恢复健康的问题。该药物是以常见的中药为原料,通过选择合理的药物及质量份比,可有效治疗上述高脂血症。
为达到上述发明的目的,本发明所采用的技术方案为:提供一种治疗高脂血症的胶囊剂药物及其制备方法,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花500~960g、荷叶50~160g、泽泻100~220g、桑白皮90~160g、枳壳30~100g、山楂100~220g、香附80~160g、金钱草150~650g、决明子80~180g、茵陈60~160g、莱菔子50~120g。
一种治疗高脂血症的胶囊剂药物及其制备方法,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花580~860g、荷叶60~140g、泽泻115~200g、桑白皮100~140g、枳壳40~90g、山楂115~200g、香附90~140g、金钱草170~550g、决明子90~160g、茵陈70~140g、莱菔子60~105g。
一种治疗高脂血症的胶囊剂药物及其制备方法,其特征在于,所述“最佳方案”的药物的各个组分及其质量份比如下所示:
白菊花750g、荷叶120g、泽泻170g、桑白皮120g、枳壳80g、山楂170g、香附120g、金钱草480g、决明子140g、茵陈120g、莱菔子95g。
一种治疗高脂血症的胶囊剂药物及其制备方法,其特征在于,所述方法包括如下步骤制备而成:
A、将上述原料中药拣去杂质、粉尘及干燥后,按照质量份比共研为极细末待用;
B、按照传统制备中药胶囊剂的方法,将研磨好的极细末药物过筛后,放入药器中混合均匀,然后制备成胶囊(其胶囊锁合后总长度为23.3mm,药粉容量0.4~0.5g/粒),进而分装密封即可。
一种治疗高脂血症的胶囊剂药物及其制备方法,其特征在于,所述服用方法为:将制备好的胶囊剂药物以每日三次服用,早中晚各服一次,给药量2g(5粒)/次,温开水送下。7天为一个疗程,服药3~6 个疗程,病获痊愈。已随访半年,未见复发。
本发明组方中的各原料中药在中国药典、中国辞典以及中华本草中均有详细的记载。本发明选用其中最常见的中药为原料,充分发挥各组分的药理功效:
白菊花,性味:甘、苦、微寒,具有养肝明目、清心、疏风、清热、解毒、健脾和胃、润喉、生津,以及调整血脂之功效,用于治疗头痛、眩晕、目赤、心胸烦热、疔疮、肿毒,并对宋氏痢疾杆菌、变形杆菌、伤寒杆菌、副伤寒杆菌、绿脓杆菌、大肠杆菌及霍乱弧菌等都有抑制作用;
荷叶,性味:苦、涩、平,具有清热解暑、升发清阳、散瘀止血之功效,用于治疗暑湿烦渴、头痛眩晕、脾虚腹胀、大便泄泻、叶血下血、产后恶露不净;
泽泻,性味:味甘、淡、性寒,具有利水渗湿、泄热通淋之功效,用于治疗小便不利、热淋涩痛、水肿胀满、泄泻、痰饮眩晕、遗精等症;
桑白皮,性味:甘、辛、性寒,具有泻肺平喘、利水消肿之功效,用于治疗肺热喘痰、水饮停肺、胀满喘急、水肿、脚气、小便不利等症;
枳壳,性味:苦、酸、性微寒,具有理气宽胸、行滞消积之功效,用于治疗胸隔痞满、胁肋胀痛、食积不化、脘腹胀满、下痢后重、脱肛、子宫脱垂;
山楂,性味:酸甘、微温、无毒,具有消食积、化滞瘀之功效,用于治疗饮食积滞、脘腹胀痛、泄泻痢疾、血瘀痛经、闭经、产后腹痛、恶露不尽;
香附,性味:味辛、微寒,无毒,具有理气解郁、调经止痛、安胎之功效,用于治疗胁肋胀痛、乳房胀育、疝气疼痛、月经不调、脘腹痞满疼痛、嗳气吞酸、呕恶、经行腹痛、崩漏带下、胎动不安、肝郁气滞、消化不良,经闭痛经;
金钱草,性味:甘、咸、微寒,具有清利湿热、通淋、消肿之功效,用于治疗热淋、沙淋、尿涩作痛、黄疸尿赤、痈肿疔疮、毒蛇咬伤、肝胆结石、尿路结石;
决明子,性味:咸苦、平凉,无毒,具有祛风清热、解毒利湿之功效,用于治疗风热感冒、流感、急性结膜炎、湿热黄疸、急慢性肾炎、带下、瘰疬、疮痈疖肿、乳腺炎;
茵陈,性味:苦、辛、微寒,具有清湿热、退黄疸之功效,用于治疗黄疸尿少、湿疮瘙痒、传染性黄疸型肝炎;
莱菔子,性味:味辛、甘、性平,具有消食导滞、降气化痰之功效,用于治疗食积气滞、脘腹胀满、腹泻、下痢后重、咳嗽多痰、气逆喘满。
本发明药物是基于中医治疗高脂血症的原则,从依据高脂血症的病理机制及药理作用认为:就高脂血症,本发明所提供的药物中的各原料中药药效共奏,对上述疾病有很好的治疗效果。
具体实施方式
本发明就是针对上述高脂血症的治疗而提出的一种中药配方,采用该配方制备的药物药效好,见效快,是一个标本兼治的中药组方,特别适合临床使用。下面结合本发明的具体实施方式作进一步详细的描述:
实施例1:
一种治疗高脂血症的胶囊剂药物,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花750g、荷叶120g、泽泻170g、桑白皮120g、枳壳80g、山楂170g、香附120g、金钱草480g、决明子140g、茵陈120g、莱菔子95g。
实施例2:
一种治疗高脂血症的胶囊剂药物,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花860g、荷叶140g、泽泻200g、桑白皮140g、枳壳90g、山楂200g、香附140g、金钱草550g、决明子160g、茵陈140g、莱菔子105g。
实施例3:
一种治疗高脂血症的胶囊剂药物,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花960g、荷叶160g、泽泻220g、桑白皮160g、枳壳100g、山楂220g、香附160g、金钱草650g、决明子180g、茵陈160g、莱菔子120g。
典型病例
经临床诊断治疗高脂血症患者共570例,年龄为42岁以上的350例,只有220例为42岁以下。570例患者中痊愈的480例,有效的90例,总有效率达100%。
Claims (3)
1.一种治疗高脂血症的胶囊剂药物,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花500~960g、荷叶50~160g、泽泻100~220g、桑白皮90~160g、枳壳30~100g、山楂100~220g、香附80~160g、金钱草150~650g、决明子80~180g、茵陈60~160g、莱菔子50~120g。
2.根据权利要求1所述的治疗高脂血症的胶囊剂药物,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花580~860g、荷叶60~140g、泽泻115~200g、桑白皮100~140g、枳壳40~90g、山楂115~200g、香附90~140g、金钱草170~550g、决明子90~160g、茵陈70~140g、莱菔子60~105g。
3.根据权利要求1至2所述的治疗高脂血症的胶囊剂药物,其特征在于,所述药物的各个组分及其质量份比如下所示:
白菊花750g、荷叶120g、泽泻170g、桑白皮120g、枳壳80g、山楂170g、香附120g、金钱草480g、决明子140g、茵陈120g、莱菔子95g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710090841.XA CN106728650A (zh) | 2017-02-20 | 2017-02-20 | 一种治疗高脂血症的胶囊剂药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710090841.XA CN106728650A (zh) | 2017-02-20 | 2017-02-20 | 一种治疗高脂血症的胶囊剂药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106728650A true CN106728650A (zh) | 2017-05-31 |
Family
ID=58958913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710090841.XA Withdrawn CN106728650A (zh) | 2017-02-20 | 2017-02-20 | 一种治疗高脂血症的胶囊剂药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106728650A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109999094A (zh) * | 2019-05-23 | 2019-07-12 | 河南中医药大学 | 一种治疗高脂血症的中药袋泡茶 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4842859A (en) * | 1986-09-08 | 1989-06-27 | Yaguang Liu | Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation |
CN102068521A (zh) * | 2011-01-13 | 2011-05-25 | 南京苏美瑞医药科技有限公司 | 一种用于治疗高脂血症的中药组合物及其制备方法和应用 |
CN103110846A (zh) * | 2013-02-22 | 2013-05-22 | 方正达 | 一种用于治疗高脂血症的中药组合物及其制备方法和应用 |
-
2017
- 2017-02-20 CN CN201710090841.XA patent/CN106728650A/zh not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4842859A (en) * | 1986-09-08 | 1989-06-27 | Yaguang Liu | Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation |
CN102068521A (zh) * | 2011-01-13 | 2011-05-25 | 南京苏美瑞医药科技有限公司 | 一种用于治疗高脂血症的中药组合物及其制备方法和应用 |
CN103110846A (zh) * | 2013-02-22 | 2013-05-22 | 方正达 | 一种用于治疗高脂血症的中药组合物及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
韦桂宁: "《小偏方胜名医 独特偏方袪白病》", 30 September 2015, 军事医学科学出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109999094A (zh) * | 2019-05-23 | 2019-07-12 | 河南中医药大学 | 一种治疗高脂血症的中药袋泡茶 |
CN109999094B (zh) * | 2019-05-23 | 2021-07-27 | 河南中医药大学 | 一种治疗高脂血症的中药袋泡茶 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103977366A (zh) | 一种治疗慢性胆囊炎的药物 | |
CN105816802A (zh) | 治疗热感冒的内服中药制剂 | |
CN104225444A (zh) | 治疗小儿肺热咳嗽的中草药组合物 | |
CN106728650A (zh) | 一种治疗高脂血症的胶囊剂药物及其制备方法 | |
CN108126066A (zh) | 一种治疗慢性鼻炎的胶囊剂药物及制备方法 | |
CN103463502A (zh) | 治疗腹胀的中药制剂 | |
CN105412665A (zh) | 一种治疗麻疹的药物及其制备方法 | |
CN104857454A (zh) | 一种治疗重症急性胰腺炎的中药汤剂 | |
CN104606538A (zh) | 一种用于预防和治疗糖尿病的中药保健品 | |
CN104324314A (zh) | 一种治疗胃病的药物组合物 | |
CN103961586B (zh) | 一种治疗外阴炎的药物及制备方法 | |
CN107982498A (zh) | 一种治疗乳腺癌的软膏剂药物及其制备方法 | |
CN103933473B (zh) | 一种补气养血祛斑美容的颗粒剂及其制备方法 | |
CN106215040A (zh) | 一种治疗哮喘的中药组合物 | |
CN105963619A (zh) | 一种治疗宫寒不孕的中药组合物 | |
CN106668510A (zh) | 一种可有效治疗咳喘的丸剂药物及其制备方法 | |
CN105998781A (zh) | 一种治疗急性胃肠炎的药物组合物 | |
CN105709005A (zh) | 一种乳康丸 | |
CN105362986A (zh) | 一种用于治疗风湿寒病的中药组合物 | |
CN104056217A (zh) | 治疗老年咳喘的中药制剂 | |
CN107753860A (zh) | 一种治疗胃癌的丸剂药物及制备方法 | |
CN104324171A (zh) | 一种治疗治疗慢性胃炎的中药制剂 | |
CN107260947A (zh) | 一种治疗高脂血症的新型中药组合物及其制备方法 | |
CN107753663A (zh) | 一种治疗乳腺癌的丸剂药物及其制备方法 | |
CN108114257A (zh) | 一种可用于治疗鼻炎的胶囊剂药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170531 |